All News


Will Roche get what it paid for?

Beyond its blockbuster drugs Genentech has a commodity rare in a large company – an entrepreneurial culture. Can Roche preserve this?

Time for a CTO in Brussels

When new European Commissioners are chosen later this year, they should take the opportunity to create a Vice President for Innovation, says Richard L. Hudson.